Robert Hendriks is Vice President, Finance, of Molecular Partners. He joined the company in March 2018 and was appointed VP, Finance in July 2019. Prior to joining Molecular Partners, Robert held finance leadership positions at uniQure of Amsterdam and Veronapharma of London, where he had a leading role in both companies’ U.S. NASDAQ IPO listings and was directly involved in other financing rounds totaling over $500 million. In addition to over 10 years of recent experience in biotech, Robert has over 20 years of experience in international financial management over a wide range of industries and in both public and private companies. Robert holds a degree in business administration from the Erasmus University in Rotterdam, Netherlands, and has attended executive education programs at Wharton School of the University of Pennsylvania and Darden School of Business at the University of Virginia.